SITUS JUDI MBL77 - AN OVERVIEW

mutations presented The point that, as described beneath, CLL therapy is predicated within the existence or absence of these mutations. The present consensus is the fact that, besides clonal mutations, subclonal mutations having a variant allelic frequency starting from five to 10% (and for that reason below the brink of detection by common molecul